![]() The findings demonstrate significant savings for commercially-insured people with both type 1 and type 2 diabetes on intensive insulin therapy when using the FreeStyle Libre 14 day system compared to routine self-monitoring of blood glucose (SMBG), also known as traditional fingerstick testing. This cost-savings includes costs associated with severe hypoglycemia, including hospitalizations, which were approximately 50% less for FreeStyle Libre 14 day system users versus testing with traditional fingersticksĪBBOTT PARK, Ill., J- Abbott, the worldwide leader in continuous glucose monitoring (CGM), announced new cost comparison data published today in U.S.Endocrinology show for commercially-insured people with diabetes on intensive insulin therapy, using FreeStyle Libre technology costs 60% less compared to traditional blood glucose monitoring ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |